New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2013
16:20 EDTBIIB, LYV, HMA, GT, VOD, ULTA, CTBOn The Fly: Closing Wrap
Stocks on Wall Street were lower despite opening sharply higher as the market looked to avoid its first three day losing streak of the year. Downside momentum quickly took hold however, and the averages moved steadily lower through the session, moving to their lows in the final hour of trading but finishing just off those levels. ECONOMIC EVENTS: In the U.S., the MBA's purchase applications composite index rose 5.0% for the week. The U.S. posted a $139B May budget deficit against expectations for a $130B deficit, and compared to a $124.6B deficit a year ago. In Europe, factory production in the 17-nation euro area rose 0.4% in April from March, compared to expectations for it to remain unchanged. COMPANY NEWS: Cooper Tire (CTB) agreed to be acquired by India's Apollo Tyres for $35.00 per share in cash, or $2.5B. Cooper shares surged $10.10, or 41.12%, to $34.66 to trade near $34.50 following the deal announcement, while peer Goodyear Tire (GT) advanced about 33c, or 2.26%, to $14.93... Live Nation (LYV) shares gained $2.33, or 16.84%, to $16.17 after the company announced it prevailed in an arbitration ruling related to a ticketing license software agreement... MAJOR MOVERS: Among the notable gainers was Ulta Salon (ULTA), up $12.51, or 14.87%, to $96.64 following its quarterly earnings report. Also higher was Health Management (HMA), up $1.58, or 11.34%, to $15.51 after Glenview Capital said in a filing it is seeking to repeal a provision that prevents entities from holding more than 15% of the company's stock and saying it would look to nominate candidates to the company's board. Among noteworthy losers was Biogen (BIIB), down $16.48, or 7.39%, to $206.55 after the stock was downgraded to Neutral from Buy at Citigroup, which cited concerns that EU medical regulators are unlikely to approve the company's multiple sclerosis treatment. Also lower were U.S.-listed shares of Vodafone (VOD), down 71c, or 2.47%, to $28.12 after the company confirmed it approached Kabel Deutschland about a possible deal. INDICES: The Dow was down 126.79, or 0.84%, to 14,995.23; the S&P 500 was down 13.61, or 0.84%, to 1,612.52; the Nasdaq was down 36.52, or 1.06%, to 3,400.43.
News For CTB;GT;LYV;ULTA;HMA;BIIB;VOD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 28, 2015
08:03 EDTULTAULTA remains compelling as business momentum continues, says Baird
Subscribe for More Information
06:50 EDTULTAULTA Q2 report increase confidence in long-term prospects, says Piper Jaffray
Subscribe for More Information
06:01 EDTBIIBStocks with implied volatility below IV index mean; BIIB TEVA
Stocks with implied volatility below IV index mean; Biogen (BIIB) 38, Teva (TEVA) 31 according to iVolatility.
August 27, 2015
18:52 EDTULTAOn The Fly: After Hours Movers
Subscribe for More Information
16:17 EDTULTAULTA Beauty rises $6.76 to $167 per share after raising FY15 guidance
16:16 EDTULTAULTA Beauty sees Q3 EPS $1.00-$1.05, consensus $1.03
Subscribe for More Information
16:15 EDTULTAULTA Beauty now sees FY15 EPS growth in high teens percentage
ULTA is raising its previously announced fiscal 2015 guidance to deliver earnings per share growth in the high teens, compared to previous guidance of the high end of the range of 15% to 17%. Consensus $4.81. The company is raising its previously announced fiscal 2015 guidance to achieve comparable sales growth of approximately 8%-10%, including the impact of the e-commerce business, compared to previous guidance of 7% to 9%. ULTA expects to increase total sales in the mid to high teens percentage range, consensus $3.85B.
16:12 EDTULTAULTA Beauty reports Q2 EPS $1.15, consensus $1.12
Subscribe for More Information
15:04 EDTULTAULTA Beauty September 160 straddle priced for 9.5% movement into Q2
14:58 EDTULTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Autodesk (ADSK), consensus 17c... ULTA Beauty (ULTA), consensus $1.12... Splunk (SPLK), consensus 2c... GameStop (GME), consensus 25c... Veeva (VEEV), consensus 11c... OmniVision (OVTI), consensus 39c... Aeropostale (ARO), consensus (55c).
12:16 EDTULTAULTA Beauty technical notes before earnings news
Shares are trading up ahead of earnings, last at $161. If the news is bullish, resistance areas to watch would be at $165.33, $171.21, and the life high at $176.77. If there is a bearish surprise, the shares given the extension in price recently would be vulnerable. Support levels to watch would be at $158.05, $153.26, and $149.13. There has been a strong line of support at the $150 area, going back to March of this year.
07:37 EDTVODLiberty Global CEO says no time frame for Vodafone discussions, Reuters says
There was no timeframe for discussions between Liberty Global (LBTYA) and Vodafone (VOD) on swapping assets, Reuters reports, citing Liberty Global's CEO. Reference Link
07:16 EDTBIIBApplied Genetic announces achievement of XLRS patient enrollement milestone
Subscribe for More Information
August 26, 2015
08:07 EDTULTAULTA Beauty should report solid Q2 results, says Baird
Subscribe for More Information
05:21 EDTVODQualcomm agrees to sell UK L-Band spectrum to Vodafone, H3G
Subscribe for More Information
August 25, 2015
16:43 EDTBIIBOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
11:22 EDTULTAULTA Beauty volatility elevated into Q2 and outlook
Subscribe for More Information
09:03 EDTBIIBAcorda has major overhang removed by IPR denials, says Leerink
Subscribe for More Information
08:41 EDTULTAULTA Beauty to report above consensus Q2 results, says William Blair
William Blair analyst Daniel Hofkin predicts that ULTA Beauty will report Q2 earnings and comp-store sales above consensus estimates and said he views the current consensus forecast for Q3 comp sales and EPS as "reasonable." Hofkin maintains an Outperform rating on ULTA shares, stating that he views its valuation as defensible and he sees opportunities for the company to continue to gain "considerable" market share and exceed margin expectations.
August 21, 2015
09:38 EDTBIIBUBS global healthcare analysts hold an analyst/industry conference call
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use